Untitled Bingo - Call List

(Print) Use this randomly generated list as your call list when playing the game. There is no need to say the BINGO column name. Place some kind of mark (like an X, a checkmark, a dot, tally mark, etc) on each cell as you announce it, to keep track. You can also cut out each item, place them in a bag and pull words from the bag.

1. periodic safety update report (PSUR)
2. Signal Assessment
3. Investigator
4. Drug Abuse
5. Organized Data Collection Program
6. GVP Module I
7. Tolerability
8. Pharmacoepidemiology
9. Drug Adverse Event Reporting System
10. Subject Matter Expert
11. Pharmacovigilance
12. Clinical Trial
13. EudraVigilance
14. Clinical Development Program
15. Periodic Safety Update Report
16. Medicines and Healthcare Regulatory Agency
17. Health Authority
18. Pharmacovigilance System Master File
19. Identified Risk
20. Aggregate Safety Report (ASR)
21. Individual Case Safety Report
22. PV Agreement
23. Development Safety Update Report
24. Post-Marketing Surveillance
25. Safety Information
26. Expectedness
27. Risk Communication
28. Regulatory authority
29. Solicited reports
30. Protocol
31. Periodic Benefit-Risk Evaluation Report
32. Product Safety Strategy
33. Adverse Event Report Number
34. Business Partner
35. Product Recall
36. Global Patient Safety
37. Good Clinical Practice
38. Side effect
39. Pharmacovigilance System
40. Suspected Unexpected Serious Adverse Reaction (SUSAR)
41. Clinical Study
42. Investigational New Drug Application
43. Labeled or unlabeled
44. New Drug Application
45. Signal Management Process
46. Medical Dictionary for Regulatory Activities (MedRA)
47. Occupational exposure
48. Signal Prioritization
49. Good Pharmacovigilance Practice
50. Healthcare Professional
51. Monitoring Plan
52. Local Safety Representative
53. BeiGene Representative
54. Refuted Signal
55. Marketing Authorization Holder
56. Clinical Study Number
57. background rates
58. Important Potential Risks
59. Urgent Safety Measure
60. Corrective and Preventive Action (CAPA)
61. Non-validated signal
62. alliance management
63. Drug Substance
64. Contract Research Organization (CRO)
65. Council for International Organizations of Medical Sciences
66. Literature Report
67. Country Safety Lead/Manager
68. Company Core Data Sheet
69. Non-serious AESI
70. Serious Adverse Event
71. Data Lock Point
72. Company Core Safety Information
73. Informed Consent
74. Causality Assessment
75. Safety Signal
76. Special Situations
77. Patient Safety
78. Blinding or Masking
79. Company Safety Committee
80. Global Safety Database
81. Business Continuity Plan
82. Comparator Product
83. Dear Investigator Letter
84. Risk Management
85. Safety Assessment Team
86. process excellence
87. Drug Product
88. Developmental Risk Management Plan
89. Off-label use
90. Non-Interventional Study
91. Reference Safety Information
92. Product Quality Complaint
93. Adverse Event (AE)
94. Interventional Study
95. National Medical Product Administration
96. Adverse Event of Special Interest (AESI)
97. International Conference on Harmonization (ICH)
98. Benefit-risk analysis
99. Affiliate
100. Risk Management Plan
101. Development International Birth Date
102. Sponsor
103. Quality Management System (QMS)
104. Unexpected Events
105. Signal Detection
106. Signal Validation
107. Institutional Review Board
108. Validated Signal
109. Risk-Benefit Balance
110. Safety Management Team
111. Safety Data Exchange Agreement
112. Investigator’s Brochure
113. Medical Review
114. Product
115. Chief Safety Officer
116. Other Safety Issue
117. Investigational Medicinal Product
118. Clinical Trial Application
119. Post-authorization Safety Study
120. Individual Case Safety Report (ICSR)
121. Signal Detection Plan
122. World Health Organization
123. Pharmacovigilance
124. Spontaneous (Unsolicited) report
125. Quality Assurance
126. Listedness/ expectedness
127. Adverse Drug Reaction (ADR)
128. Observational study
129. Overdose
130. Qualified Person for Pharmacovigilance